Ultragenyx Pharmaceutical Inc. (RARE) announced Phase 1/2 data in support of the Phase 3 Aspire study for GTX-102, its ...

A four-year-old girl, who doctors said would never walk, has defied expectations to take her first steps. When she was a baby, Scottie Mae Blair was diagnosed with Angelman syndrome—a rare genetic ...